Linked Life Data

3128235

Source:http://linkedlifedata.com/resource/pubmed/id/3128235

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1988-5-10
pubmed:abstractText
Secondary prevention of myocardial infarction includes all measures likely to reduce morbidity and mortality after the infarction. It is a highly heterogeneous concept applied to a highly heterogeneous disease. The natural history of myocardial infarction, which must be known to determine the frequency of critical events and hence devise a trial, is incomplete particularly since treatment capable of altering this history (aorto-coronary bypass, thrombolysis) have been introduced. Future trials in secondary prevention of myocardial infarction must concentrate on such important questions as: can the possibilities of reperfusion be extended as regards the acute phase, and which preventive measures are useful to patients at high risk post-infarction? The A.P.S.I. study (acetolol in the secondary prevention of myocardial infarction) is an example of study aimed at answering the second question.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-9683
pubmed:author
pubmed:issnType
Print
pubmed:volume
80 Spec No
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
67-71
pubmed:dateRevised
2009-2-13
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
[Quantitative evaluation of myocardial ischemia using imaging methods].
pubmed:affiliation
Clinique cardiologique, CHU Dupuytren, Limoges.
pubmed:publicationType
Journal Article, English Abstract